Target antigen . | Staining pattern . | Clinical association . |
---|---|---|
Proteinase 3 | C-ANCA (90%) P-ANCA (2%) | WG, microscopic polyarteritis, Churg–Strauss (30%) |
Myeloperoxidase | P-ANCA (70%) P-ANCA (5%) | WG, microscopic polyarteritis, Churg–Strauss (60%), GBM (30%) |
Azuocidin (CAP37) | P-ANCA | Uncertain |
β-glucuronidase | P-ANCA | Uncertain |
Bactericidal permeability-increasing protein (BPI) | C-ANCA (4%) atypical ‘flat’ ANCA | Cystic fibrosis (50%) |
Cathepsin G | P-ANCA (5%) X-ANCA | Sclerosing cholangitis, ulcerative colitis |
Elastase | P-ANCA (8%) X-ANCA | SLE (neuro-SLE), hydralazine-induced SLE, RhA, ulcerative colitis |
Lactoferrin | P-ANCA (10%) X-ANCA | Inflammatory bowel disease, PBC, AIH, SLE, RhA |
Lysozyme | C-ANCA P-ANCA | Uncertain |
Target antigen . | Staining pattern . | Clinical association . |
---|---|---|
Proteinase 3 | C-ANCA (90%) P-ANCA (2%) | WG, microscopic polyarteritis, Churg–Strauss (30%) |
Myeloperoxidase | P-ANCA (70%) P-ANCA (5%) | WG, microscopic polyarteritis, Churg–Strauss (60%), GBM (30%) |
Azuocidin (CAP37) | P-ANCA | Uncertain |
β-glucuronidase | P-ANCA | Uncertain |
Bactericidal permeability-increasing protein (BPI) | C-ANCA (4%) atypical ‘flat’ ANCA | Cystic fibrosis (50%) |
Cathepsin G | P-ANCA (5%) X-ANCA | Sclerosing cholangitis, ulcerative colitis |
Elastase | P-ANCA (8%) X-ANCA | SLE (neuro-SLE), hydralazine-induced SLE, RhA, ulcerative colitis |
Lactoferrin | P-ANCA (10%) X-ANCA | Inflammatory bowel disease, PBC, AIH, SLE, RhA |
Lysozyme | C-ANCA P-ANCA | Uncertain |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.